摘要
目的 探究暖肺祛瘀汤复合异丙托溴铵治疗慢性阻塞性肺疾病（COPD）急性加重期患者临床效果.方法 选取我院2014年5 月～ 2016 年9 月COPD 急性加重期患者93 例,建档顺序分组,对照组46 例予以异丙托溴铵治疗,研究组47 例予以暖肺祛瘀汤复合异丙托溴铵治疗,两组均持续治疗2 周,统计比较两组临床效果,分析比较两组治疗前后生活质量评分变化.结果研究组治疗总有效率95.74%（45/47）高于对照组73.91%（34/46）,差异有统计学意义（P 〈 0.05）;两组治疗前躯体功能、认知功能、精力、生活满足感等生活质量评分比较差异无统计学意义（P 〉 0.05）,研究组治疗后躯体功能、认知功能、精力、生活满足感等生活质量评分与对照组相比均较高,差异有统计学意义（P 〈 0. 05）.结论 暖肺祛瘀汤复合异丙托溴铵治疗COPD 急性加重期患者临床效果显著,有助于提升其生活质量.
Objective To explore the clinical effect of Nuanfei Quyu tang combination Ipratropium bromide in the treatmentof acute exacerbation of chronic obstructive pulmonary disease （COPD）. Methods 93 p atients w ith a cute exacerbation ofCOPD from May 2014 to September 2016 in our hospital were selected,grouped by filing order,the control group of 46 caseswere treated with ipratropium bromide,the 47 patients in the study group were treated with Nuanfei Quyu tang combinationIpratropium bromide,2 groups were treated continuously for 2 weeks, and the clinical effects were compared between the 2groups, and analyzed and compared Analysis of quality of life scores before and after treatment. Results The total effectiverate of treatment group was 95.74% （45/47）, which was higher than that of control group 73.91% （34/46）, and the difference wasstatistically significant （P〈 0.05）; There was no significant difference in the physical function, cognitive function, energy, lifesatisfaction and other quality of life scores between the two groups before treatment （P〉0.05）, ,while after treatment, the studygroup was higher than the control group, the difference was statistically significant （P〈0.05）. Conclusion The clinical effect ofNuanfei Quyu tang combination Ipratropium bromide in patients with acute exacerbation of COPD is significant, and it help toimprove the quality of life.
出处
《临床研究》
2017年第8期137-138,共2页
Clinical Research
